I. Giuliani

Prohormone brain natriuretic peptide (proBNP), BNP and N-terminal-proBNP circulating levels in chronic hemodialysis patients. Correlation with ventricular function, fluid removal and effect of hemodiafiltration

K. Klouche, J. Cristol, A. Dupuy, 2008, Clinical chemistry and laboratory medicine.

Assay for measurement of intact B-type natriuretic peptide prohormone in blood.

C. Granier, B. Pau, J. Cristol, 2006, Clinical chemistry.

Role for precursor Pro-B type natriuretic peptide in assessing response to therapy and prognosis in patients with decompensated heart failure treated with nesiritide.

Karen A. Hartman, A. Jaffe, D. Hodge, 2009, Clinica chimica acta; international journal of clinical chemistry.

Earlier detection of myocardial infarction by an improved cardiac TnI assay.

C. Larue, A. Polge, J. Bertinchant, 2007, Clinical biochemistry.

Evaluation of cardiac troponin I and T levels as markers of myocardial damage in doxorubicin-induced cardiomyopathy rats, and their relationship with echocardiographic and histological findings.

C. Granier, M. Dauzat, P. Fabbro-Péray, 2003, Clinica chimica acta; international journal of clinical chemistry.

Determination of cardiac troponin I forms in the blood of patients with unstable angina pectoris.

C. Granier, B. Pau, C. Larue, 2002, Clinical biochemistry.

Analytical assay characterization for 1-108 pro-B-type natriuretic peptide on the BioPlex 2200 analyzer.

A. Wu, E. Rame, F. Wians, 2009, Clinica chimica acta; international journal of clinical chemistry.

New epitope of the bnp (1-32) and antibodies directed against this epitope

F. Rieunier, I. Giuliani, S. Villard, 2007 .

Determination of cardiac troponin I forms in the blood of patients with acute myocardial infarction and patients receiving crystalloid or cold blood cardioplegia.

G. Toubin, C. Granier, C. Larue, 1999, Clinical chemistry.